Utility of 18F-NaF PET/CT Imaging in Prostate Cancer

You’re invited to an online meeting:
Utility of 18F-NaF PET/CT Imaging in Prostate Cancer
Presenter: Robert Bridwell, M.D., M.B.A., Medical Advisor to IBA Molecular
Dr. Robert Bridwell, medical advisor to IBA Molecular North America, and co-founder of PETLinQ, is a board-certified
physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous
quality improvement programs for PET and PET/CT imaging, utilizing physician empowerment training, protocol
development assistance, and quality assurance guidelines. In the last five years, Dr. Bridwell has been invited to
make numerous presentations, which have included more than 1200 hours of CME credit delivered to more than 350
institutions, 100 professional society meetings and more than 150 radiology groups throughout the United States,
Canada and Europe.
Who should attend? Referring Physicians, PET Interpreters, Technologists, Marketers
In this session, Dr. Bridwell will:
Compare the relative sensitivity, specificity and accuracy of 18F-NaF PET/CT and TC99 MDP planar bone imaging in the detection of skeletal metastases
Discuss specific clinical settings for Prostate Cancer where accurate identification of bone metastases may impact the management of patients
Detail current literature and guidelines regarding the use of 18F-NaF PET/CT for this indication
Review case studies to illustrate where 18F-NaF PET/CT can deliver important diagnostic information to the clinician
Open the session for your questions regarding appropriate and effective approaches regarding this topic
To receive CE credit you must register individually, attend the entire session and complete a post-webinar survey.
Instructions regarding receiving CEH (1.0) will be provided at the conclusion of the session.
This webinar is part of
our Appropriate Use
Initiative, supporting the
evidence-based utilization
of advanced imaging to
improve patient care and
outcomes. The stamp
identifies each of the
educational elements
available in this program.
Go to ibamolecular.
com/appropriateuse for
more information.
Register Today!
Utility of 18F-NaF PET/CT Imaging in Prostate Cancer
Event Date: Tuesday, March 25, 2014
Event Time: 3:00 pm, EDT
or go to https://www4.gotomeeting.com/register/699491127
Upon registration approval, you will receive a confirmation email with the information to
join the webinar and teleconference.
Provided exclusively for IBA Molecular customers.
This webinar is part of IBA Molecular’s Appropriate Use Initiative. For a full 2014
schedule, please visit http://www.ibamolecular.com/educational-learning-series or ask
your IBA Molecular clinical account executive.
IBA Molecular North America, Inc. 21000 Atlantic Blvd., Suite 730 | Dulles, VA 20166 | Toll Free: 1 877 334 3673 | Tel.: + 1 703 787 7900 | Fax: + 1 571 434 0330 | www.ibamolecular.com
March 2014 | ELS Webinar Invitation © IBA Molecular North America, Inc. 2014 / All Rights Reserved.